Knowledge Management System Of Institute of process engineering,CAS
| The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity | |
| Yu, Rui1; Xu, Junjie1; Hu, Tao2; Chen, Wei1 | |
| 2020-07-04 | |
| Source Publication | MEDIATORS OF INFLAMMATION
 |
| ISSN | 0962-9351 |
| Volume | 2020Pages:11 |
| Abstract | The encapsulated bacteria, asStreptococcus pneumonia,Haemophilus influenzaetype b, andNeisseria meningitidis, cause serious morbidity and mortality worldwide. The capsular polysaccharide (PS), which could elicit a weak T cell-independent immune response, is a vital virulence determinant. One of the strategies to improve the PS-specific immunogenicity is to conjugate PS with a nontoxic carrier protein. Tetanus toxoid (TT) and CRM197 are the typical carrier proteins for the PS conjugate vaccines. TT is the inactivated tetanus toxin manipulated with formaldehyde, which suffers from the pollution from residual formaldehyde and the incomplete detoxification. CRM197 has the disadvantage of low-yield purification with the requirement of sophisticated culture conditions. Thus, a novel carrier protein without these disadvantages is highly required. The tetanus toxin native C-fragment (Hc) is safe, low-cost, and highly immunogenic with easy purification, which can act as a promising carrier protein. Pneumococcal serogroups 14 and 23F were major epidemic causes of pneumococcal infections. In the present study, the capsular PSs (PS14 and PS23F) were conjugated with Hc, TT, and CRM197, respectively. TT- and CRM197-based conjugates acted as controls for Hc-based conjugates (PS14-Hc and PS23F-Hc). The structural properties of Hc were not fundamentally changed after conjugated with PS. PS14-Hc and PS23F-Hc could potentiate sound PS-specific antibody levels comparable to the controls. Thus, Hc exhibited a practical carrier effect to help the pneumococcal conjugate vaccines perform good immunogenicities. |
| DOI | 10.1155/2020/9596129 |
| Language | 英语 |
| WOS Keyword | PROTEIN CARRIERS ; IMPROVES ; DISEASE |
| Funding Project | National Key Research and Development Project of China[2018YFA0900804] ; National Natural Science Foundation of China[31970875] ; National Natural Science Foundation of China[81703445] |
| WOS Research Area | Cell Biology ; Immunology |
| WOS Subject | Cell Biology ; Immunology |
| Funding Organization | National Key Research and Development Project of China ; National Natural Science Foundation of China |
| WOS ID | WOS:000552753300001 |
| Publisher | HINDAWI LTD |
| Citation statistics | |
| Document Type | 期刊论文 |
| Identifier | http://ir.ipe.ac.cn/handle/122111/41592 |
| Collection | 中国科学院过程工程研究所 |
| Corresponding Author | Hu, Tao; Chen, Wei |
| Affiliation | 1.Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 100071, Peoples R China 2.Chinese Acad Sci, Inst Proc Engn, State Key Lab Biochem Engn, Beijing 100190, Peoples R China |
| Recommended Citation GB/T 7714 | Yu, Rui,Xu, Junjie,Hu, Tao,et al. The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity[J]. MEDIATORS OF INFLAMMATION,2020,2020:11. |
| APA | Yu, Rui,Xu, Junjie,Hu, Tao,&Chen, Wei.(2020).The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity.MEDIATORS OF INFLAMMATION,2020,11. |
| MLA | Yu, Rui,et al."The Pneumococcal Polysaccharide-Tetanus Toxin Native C-Fragment Conjugate Vaccine: The Carrier Effect and Immunogenicity".MEDIATORS OF INFLAMMATION 2020(2020):11. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment